Literature DB >> 6257777

Hepatitis A virus infections in Voyvodina.

B S Vuković, N Roncević, R Borota, A L Terzin.   

Abstract

Sera of 1000 persons in Voyvodina were tested with radioimmunoassay for antibodies against hepatitis A virus (HAV). The morbidity and age incidence of positive findings have been analysed and compared with relevant findings in other countries. Below the age of 19 years the morbidity rates are higher (0.138 to 0.595 per mill) and the prevalences of seropositives are lower (17.1-64.0%) than the respective frequencies above that age (0.011 to 0.052 per mill and 85.7-98.7% respectively). Below the first year of life seropositivity is more frequent than in 1- to 14-year old children. After the first year until the age of 30-39 years the frequency of seropositives increases with increasing age up to a maximum of about 90%.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6257777      PMCID: PMC2134071          DOI: 10.1017/s0022172400068790

Source DB:  PubMed          Journal:  J Hyg (Lond)        ISSN: 0022-1724


  7 in total

1.  Prevalence of antibody to hepatitis A and polioviruses in an unimmunized urban population.

Authors:  I D Gust; F A Lewis; N I Lehmann
Journal:  Am J Epidemiol       Date:  1978-01       Impact factor: 4.897

2.  The prevalence of antibody to hepatitis A antigen in various parts of the world: a pilot study.

Authors:  W Szmuness; J L Dienstag; R H Purcell; C E Stevens; D C Wong; H Ikram; S Bar-Shany; R P Beasley; J Desmyter; J A Gaon
Journal:  Am J Epidemiol       Date:  1977-11       Impact factor: 4.897

3.  A microtiter solid-phase radioimmunoassay for hepatitis A antigen and antibody.

Authors:  R H Purcell; D C Wong; Y Moritsugu; J L Dienstag; J A Routenberg; J D Boggs
Journal:  J Immunol       Date:  1976-02       Impact factor: 5.422

4.  A seroepidemiologic study of infection with HAV and HBV in five Pacific Islands.

Authors:  I D Gust; N I Lehmann; M Dimitrakakis
Journal:  Am J Epidemiol       Date:  1979-09       Impact factor: 4.897

5.  Seroepidemiologic investigations of human hepatitis caused by A, B, and a possible third virus.

Authors:  V M Villarejos; P J Provost; O L Ittensohn; A A McLean; M R Hilleman
Journal:  Proc Soc Exp Biol Med       Date:  1976-09

6.  Distribution of antibody to hepatitis a antigen in urban adult populations.

Authors:  W Szmuness; J L Dienstag; R H Purcell; E J Harley; C E Stevens; D C Wong
Journal:  N Engl J Med       Date:  1976-09-30       Impact factor: 91.245

7.  Antibody against hepatitis A in seven European countries. I. Comparison of prevalence data in different age groups.

Authors:  G G Frösner; G Papaevangelou; R Bütler; S Iwarson; A Lindholm; A Couroucé-Pauty; H Haas; F Deinhardt
Journal:  Am J Epidemiol       Date:  1979-07       Impact factor: 4.897

  7 in total
  2 in total

1.  Antibody to hepatitis A virus after overt and asymptomatic hepatitis A infection.

Authors:  S A Prikazchikov; M S Balayan
Journal:  Eur J Epidemiol       Date:  1986-03       Impact factor: 8.082

2.  Declining seroprevalence of hepatitis A in Vojvodina, Serbia.

Authors:  Snežana Medić; Cleo Anastassopoulou; Vesna Milošević; Nataša Dragnić; Smiljana Rajčević; Mioljub Ristić; Vladimir Petrović
Journal:  PLoS One       Date:  2019-06-04       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.